Shepherd Financial Partners LLC decreased its position in Danaher Co. (NYSE:DHR – Free Report) by 2.7% in the 4th quarter, Holdings Channel.com reports. The fund owned 8,850 shares of the conglomerate’s stock after selling 249 shares during the period. Shepherd Financial Partners LLC’s holdings in Danaher were worth $2,032,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also made changes to their positions in the company. Wedge Capital Management L L P NC increased its stake in Danaher by 3.2% during the third quarter. Wedge Capital Management L L P NC now owns 1,231 shares of the conglomerate’s stock valued at $342,000 after purchasing an additional 38 shares during the last quarter. Meridian Financial Partners LLC boosted its holdings in shares of Danaher by 4.4% in the 3rd quarter. Meridian Financial Partners LLC now owns 957 shares of the conglomerate’s stock valued at $266,000 after buying an additional 40 shares during the period. Kovack Advisors Inc. raised its stake in Danaher by 3.4% during the third quarter. Kovack Advisors Inc. now owns 1,243 shares of the conglomerate’s stock worth $346,000 after acquiring an additional 41 shares during the period. Well Done LLC lifted its holdings in Danaher by 1.2% in the third quarter. Well Done LLC now owns 3,551 shares of the conglomerate’s stock worth $987,000 after acquiring an additional 42 shares during the last quarter. Finally, Waypoint Capital Advisors LLC boosted its stake in Danaher by 0.9% in the third quarter. Waypoint Capital Advisors LLC now owns 4,520 shares of the conglomerate’s stock valued at $1,257,000 after acquiring an additional 42 shares during the period. 79.05% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
DHR has been the topic of several recent research reports. Robert W. Baird cut their price target on Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Raymond James reiterated a “market perform” rating on shares of Danaher in a research note on Monday, February 3rd. JPMorgan Chase & Co. lowered their price target on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Scotiabank initiated coverage on shares of Danaher in a research report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price objective on the stock. Finally, StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Seven investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $278.00.
Danaher Price Performance
Shares of NYSE DHR opened at $206.92 on Friday. Danaher Co. has a twelve month low of $205.79 and a twelve month high of $281.70. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The firm has a 50-day moving average of $233.38 and a two-hundred day moving average of $252.10. The company has a market capitalization of $149.45 billion, a price-to-earnings ratio of 39.19, a PEG ratio of 2.80 and a beta of 0.83.
Danaher (NYSE:DHR – Get Free Report) last issued its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the business posted $2.09 EPS. As a group, analysts expect that Danaher Co. will post 7.77 earnings per share for the current fiscal year.
Danaher Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.52%. The ex-dividend date was Friday, December 27th. Danaher’s dividend payout ratio is presently 20.45%.
Insiders Place Their Bets
In other news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 10.90% of the company’s stock.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
- Five stocks we like better than Danaher
- The 3 Best Blue-Chip Stocks to Buy Now
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- What Are Earnings Reports?
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.